Tien Liang BioTech Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 108.31 million compared to TWD 121.62 million a year ago. Net loss was TWD 1.44 million compared to net income of TWD 9.06 million a year ago. Basic loss per share from continuing operations was TWD 0.03 compared to basic earnings per share from continuing operations of TWD 0.2 a year ago. Diluted loss per share from continuing operations was TWD 0.03 compared to diluted earnings per share from continuing operations of TWD 0.2 a year ago.
For the nine months, sales was TWD 343.38 million compared to TWD 394.74 million a year ago. Net income was TWD 10.52 million compared to TWD 44.02 million a year ago. Basic earnings per share from continuing operations was TWD 0.23 compared to TWD 0.96 a year ago. Diluted earnings per share from continuing operations was TWD 0.23 compared to TWD 0.96 a year ago.